Lv2
170 积分 2022-04-11 加入
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years
7天前
已完结
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
2个月前
已完结
Recent progress in ITP treatment
2个月前
已完结
BTK inhibitors: past, present, and future
2个月前
已完结
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
2个月前
已完结
Risk of bleeding associated with BTK inhibitor monotherapy: a systematic review and meta-analysis of randomized controlled trials
2个月前
已完结
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
3个月前
已完结
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
3个月前
已完结
Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
3个月前
已完结
Primary biliary cholangitis in patients with inflammatory bowel disease
3个月前
已完结
皖公网安备34019202002308
